Castro PM, González NI, Pérez LJ

Language: English
References: 26
Page: 35-40
PDF size: 93.81 Kb.

ABSTRACT

INTRODUCTION In recent years, global initiatives to address the AIDS epidemic have produced promising advances through access to effective treatment programs. However, lack of adherence to antiretroviral therapy is a problem for pediatric patients.
OBJECTIVES Explore antiretroviral therapy adherence in children and adolescents living with HIV/AIDS in Cuba and examine its relationship with psychosocial, individual and treatment factors.
METHODS A qualitative study was carried out of 21 caregivers of children and adolescents with HIV/AIDS. Demographics and information on treatment regimen were collected by chart review. In-depth interviews were conducted to assess adherence and examine its relationship with psychosocial, individual and treatment factors. Interviews were transcribed and the information was grouped by factor category. Adherence was analyzed in relation to these three sets of factors.
RESULTS Caregivers interviewed reported adequate adherence in 17 of the 21 children. Lack of adherence was linked primarily to psychosocial factors such as additional responsibility taken on by the caregiver while grappling with his or her own illness, the presence of untreated psychological symptoms in the caregiver, perceived difficulties with family support, the child's age, and assigning treatment responsibilities to the child without taking into account his/her psychological maturity.
CONCLUSIONS The study revealed a high level of antiretroviral therapy adherence. It reconfirmed the fundamental importance of the caregiver and family support for therapeutic success in children and adolescents living with HIV/AIDS. These results, as well as the factors identified in cases of nonadherence, can contribute to a framework for assessment and specialized interventions to optimize pediatric antiretroviral adherence.

REFERENCES

1. UNAIDS [Internet]. Geneva: UNAIDS; c2014. Epidemic Update; 2010 [cited 2010 Apr 4]. Available from: http://www.unaids.org/en/HIV_data/ epi20

2. Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS. The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS. 2010 Oct;24(10):639–49.

3. World Health Organization [Internet]. Guidelines on HIV and infant feeding 2010. Geneva: World Health Organization; 2011 [cited 2011 Jun 20]. 58 p. Available from: http://whqlibdoc.who.int/publi cations/2010/9789241599535_eng.pdf

4. Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, et al. Declines in mortality rates and changes in causes of death in HIV-1–infected children during the HAART era. J Acquir Immune Defi c Syndr. 2010 Jan;53(1):86–94.

5. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008 Aug;8(8):477–89.

6. Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral- naïve cohort initiating triple antiretroviral therapy. J Infect Dis. 2005 Feb 1;191(3):339–47.

7. Lindsey JC, Malee KM, Brouwers P, Hughes MD; PACTG 219C Study Team. Antiretroviral therapy before and after the introduction of protease inhibitor–based highly active neurodevelopmental functioning in HIV-infected infants and young children. Pediatrics. 2007 Mar;119(3):e681–93.

8. Resino S, Bellón JM, León JA, Resino R, Muñoz MA; Grupo Español de Infección Pediátrica VIH. Carga viral plasmática en niños infectados por el virus de la inmunodefi ciencia humana que reciben tratamiento antirretroviral de gran actividad. Med Clin (Barc). 2007 Jan 20;128(2):49–51. Spanish.

9. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middleincome countries. Pediatr Infect Dis J. 2008 Aug;27(8):686–91.

10. Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, et al. A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers. AIDS Patient Care STDS. 2009 Aug;23(8):593–601.

11. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007 Jun;119(6):e1371–83.

12. Muyingo SK, Walker AS, Reid A, Munderi P, Gibb DM, Ssali F, et al. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the fi rst year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defi c Syndr. 2008 Aug 1;48(4):468–75.

13. Ministry of Public Health (CU). Plan estratégico nacional ITS/VIH/SIDA [Internet]. Havana: Ministry Public Health (CU); 2009 [cited 2011 Jun 20]. 34 p. Available from: http://fi les.sld.cu/sida/ files/2011/08/informacion_practica_para_la _atencion_integral_a_pvs-2009.pdf. Spanish.

14. Aragonés C, Sánchez L, Campos J, Pérez J. Antiretroviral therapy adherence in persons with HIV/AIDS in Cuba. MEDICC Rev [Internet]. 2011 Apr [cited 2012 Jun 20];13(2):17–23. Available from: http://www.medicc.org/mediccreview/ index.php?issue=16&id=192&a=va

15. Merzel C, VanDevanter N, Irvine M. Adherence to antiretroviral therapy among older children and adolescents with HIV: a qualitative study of psychosocial contexts. AIDS Patient Care STDS. 2008 Dec;22(12):977–87.

16. Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F. Barriers and facilitators of adherence to pediatric antiretroviral therapy in a Sub-Saharan setting: insights from a qualitative study. AIDS Patient Care STDS. 2011 Oct;25(10):611–21.

17. Davies MA, Bo ulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008 Sep 4;8:34.

18. Vaz LM, Eng E, Maman S, Tshikandu T, Behets F. Telling children they have HIV: lessons learned from fi ndings of qualitative study in Sub- Saharan Africa. AIDS Patient Care STDS. 2010 Apr;24(4):247–56.

19. Steele RG, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev. 2003 Mar;6(1):17–30.

20. Llabre MM, Weaver KE, Durán RE, Antoni MH, McPherson-Baker S, Schneiderman N. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care STDS. 2006 Oct;20(10):701–11.

21. Patton MQ. Qualitative research and evaluation methods. 3rd ed. California: Sage Publications; 2001 Oct 31. 688 p.

22. Centers for Disease Control and Prevention. 1994 revised classifi cation system for human immunodefi ciency virus infection in children less than 13 years of age. MMWR [Internet]. 1994 Sep 30 [cited 2012 Jun 20];43(RR–12):1–10. Available from: http://www.cdc.gov/mmwr/PDF/ rr/rr4312.pdf

23. Kikuchi K, Poudel KC, Muganda J, Majyambere A, Otsuka K, Sato T. High risk of ART nonadherence and delay of ART initiation among HIV positive double orphans in Kigali, Rwanda. PLoS ONE. 2012;7(7):e41998.

24. Burgess SW, Sly PD, Morawska A, Devadason SG. Assessing adherence and factors associated with adherence in young children with asthma. Respirology. 2008 Jun;13(4):559–63.

25. Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois PA, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006 Dec;118(6):e1745–57.

26. Marhefka SL, Koenig LJ, Allison S, Bachanas P, Bulterys M, Bettica L, et al. Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care STDS. 2008 Aug;22(8):637–47.